Cargando…

Nuclear matrix protein SMAR1 control regulatory T-cell fate during inflammatory bowel disease (IBD)

Regulatory T (T(reg)) cells are essential for self-tolerance and immune homeostasis. Transcription factor Foxp3, a positive regulator of T(reg) cell differentiation, has been studied to some extent. Signal transducer and activator of transcription factor 3 (STAT3) is known to negatively regulate Fox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirlekar, B, Ghorai, S, Khetmalas, M, Bopanna, R, Chattopadhyay, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762908/ https://www.ncbi.nlm.nih.gov/pubmed/25993445 http://dx.doi.org/10.1038/mi.2015.42

Ejemplares similares

Regulation of T cell lineage commitment by SMAR1 during inflammatory & autoimmune diseases
por: Mirlekar, Bhalchandra, et al.
Publicado: (2015)

Nuclear matrix binding protein SMAR1 regulates T-cell differentiation and allergic airway disease
por: Chemmannur, S V, et al.
Publicado: (2015)

Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice
por: Chemmannur, Sijo V, et al.
Publicado: (2016)

Chromatin Remodeling Protein SMAR1 Is a Critical Regulator of T Helper Cell Differentiation and Inflammatory Diseases
por: Mirlekar, Bhalchandra, et al.
Publicado: (2017)

SMAR1 coordinates HDAC6-induced deacetylation of Ku70 and dictates cell fate upon irradiation
por: Chaudhary, N, et al.
Publicado: (2014)

Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex
por: Paul, Debasish, et al.
Publicado: (2017)

SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression
por: Taye, Nandaraj, et al.
Publicado: (2018)

SMAR1 binds to T(C/G) repeat and inhibits tumor progression by regulating miR-371-373 cluster
por: Mathai, Jinumary, et al.
Publicado: (2016)

Tumor suppressor protein SMAR1 modulates the roughness of cell surface: combined AFM and SEM study
por: Kaul-Ghanekar, Ruchika, et al.
Publicado: (2009)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment
por: Singh, Sandeep, et al.
Publicado: (2012)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Correction to: Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment
por: Singh, Sandeep, et al.
Publicado: (2020)

RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway
por: Firmal, Priyanka, et al.
Publicado: (2022)

SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression
por: Alam, Aftab, et al.
Publicado: (2019)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
por: Dykes, Dana, et al.
Publicado: (2016)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
por: Markiewicz-Łoskot, Grażyna, et al.
Publicado: (2023)

Complete Genome Sequence of Serratia marcescens Myophage MyoSmar
por: Cooper, Savannah, et al.
Publicado: (2019)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
por: Tavassoli, Samane, et al.
Publicado: (2021)

Stabilization of SMAR1 mRNA by PGA2 involves a stem–loop structure in the 5′ UTR
por: Pavithra, Lakshminarasimhan, et al.
Publicado: (2007)

Capsaicin-Induced Activation of p53-SMAR1 Auto-Regulatory Loop Down-Regulates VEGF in Non-Small Cell Lung Cancer to Restrain Angiogenesis
por: Chakraborty, Samik, et al.
Publicado: (2014)

Constitutive expression of SMAR1 confers susceptibility to Mycobacterium tuberculosis infection in a transgenic mouse model
por: Yadav, Bhawna, et al.
Publicado: (2015)

Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID‐19 pandemic
por: Ling, Khoon Lin, et al.
Publicado: (2020)

Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry
por: Torres, Esther A., et al.
Publicado: (2012)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

Neutrophil-to-Lymphocyte Ratio (NLR) in Canine Inflammatory Bowel Disease (IBD)
por: Benvenuti, Elena, et al.
Publicado: (2020)

Detection of Anti-Erythrocyte Antibodies in Dogs with Inflammatory Bowel Disease (IBD)
por: Gori, Eleonora, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sc7ceh56bulagfth6q1jjl7gnr